Posters Modérés (PM1) - Zone jaune - Session translationnelle - Oncopharmacologie

• 141 • PM1-001 - Comparison of clinical safety between standard versus extended interval dosing of immune checkpoint inhibitors > P. Pascale Palassin • 193 • PM1-002 - Venetoclax exposure-safety relationships in real life Acute Myeloïd Leukemia (AML) patients > F. Florent Puisset • 203 • PM1-003 - Glucarpidase rescue in patients with delayed methotrexate clearance: is there a clinical benefit? > S. Sabrina Pierre • 210 • PM1-004 - Pharmacovigilance contribution in a onco-cardio-pharmacology multidisciplinary team meeting > M. Marion Sassier • 265 • PM1-005 - STK11/LKB1 mutation in non-small cell lung cancer: prognostic or predictive? > P. Pietro ROSELLINI • 345 • PM1-006 - Ex vivo histoculture drug response assay to uncover therapeutic opportunities in NRASQ61 mutated melanoma. > C. Coralie Reger De Moura • 378 • PM1-007 - Pharmacogenetic effects on 5-fluorouracil therapy in cancer patients > A. Asma Omezzine